Lansoprazole/Naproxen

兰索拉唑/萘普生

Report date: 2023/04/25 13:51:17

Base Information

Drug NameLansoprazole/Naproxen
Drug Alias NameNaproxen/Lansoprazole萘普生/兰索拉唑兰索拉唑+萘普生Lansoprazole and NaproxenPrevacid NapraPAC500 +[8] 
ClassificationSmall molecules
Mechanisms of ActionProton pump inhibitorsCyclooxygenases inhibitors
TargetsProton pumpCyclooxygenases
Therapy Area/IndicationsStomach Ulcer
Global Approved IndicationsStomach Ulcer
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/11/14
Country/TerritoryUnited States
CombinationsYes NaproxenLansoprazole
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharms Na
Active IndicationsN/A
Inactive IndicationsStomach Ulcer

Other Information

ATC CodeM01AE
Related LinksN/A